Answers are grounded in this paper and cite their sources.
Guidelines standardize clinical practice and decision-making for hematopoietic stem cell transplantation in China.
Hematopoietic stem cell transplantation (HSCT) is used to treat various hematologic diseases, including autologous and allogeneic transplants. As the indications for HSCT have expanded and its clinical application has become more widespread, it is essential to ensure standardized and appropriate use of techniques. A comprehensive assessment of HSCT is an important step in clinical decision-making. To standardize diagnosis and treatment in HSCT clinical practice, an expert panel from the Chinese Collaborative Group on the Transformation of Infectious Immunology and Microecology Research participated in this evaluation to provide guidance for the management of HSCT in clinical practice.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: